The “1 in 2” figure is higher than current U.S. data supports. Based on 2021–2023 data from the National Cancer Institute’s SEER program, approximately 39.2% of Americans will be diagnosed with cancer at some point in their lifetime. That’s closer to 2 in 5 than 1 in 2. The statistic has been widely cited in the UK, where Cancer Research UK previously estimated a roughly 50% lifetime risk, but the number varies by country, sex, and how the calculation is done.
Either way, the core message holds: cancer is extraordinarily common. Understanding what that number actually means, and what drives it, can help you put your own risk in perspective.
What “Lifetime Risk” Actually Measures
Lifetime risk is the probability that a person will develop cancer at any point from birth to death. It’s not the chance you’ll get cancer this year, or in the next five years. It’s a cumulative number that stacks up every year of life into a single figure.
To illustrate: an American woman’s lifetime risk of colorectal cancer is about 4%, or 40 out of every 1,000 women. But her risk of developing that same cancer before age 50 is just 0.4%, or 4 out of 1,000. The lifetime number captures decades of accumulated risk, most of it concentrated in older age. That distinction matters because the statistic can sound alarming without that context.
Age Is the Biggest Factor
Cancer is overwhelmingly a disease of aging. The incidence rate climbs from fewer than 26 cases per 100,000 people in age groups under 20, to about 350 per 100,000 among those aged 45 to 49, to more than 1,000 per 100,000 in age groups 60 and older. The median age at diagnosis is 67, meaning half of all cancer cases occur in people older than that.
Different cancers cluster at different ages. The median diagnosis age is 63 for breast cancer, 66 for colorectal cancer, 68 for prostate cancer, and 71 for lung cancer. This is why lifetime risk statistics are so high: they assume you live long enough to reach the ages where cancer becomes common. In a population where people die younger from other causes, the lifetime cancer risk would be lower, not because cancer is rarer biologically, but because fewer people survive to the peak-risk years.
Men Face Higher Rates Than Women
Cancer does not affect men and women equally. In the U.S., the rate of new cancer cases is 488.3 per 100,000 for men compared to 426.2 per 100,000 for women. That gap reflects differences in biology, hormonal factors, and historically higher rates of smoking and occupational exposures among men. The combined 39.2% lifetime risk figure blends both sexes together, so individual risk will be somewhat higher or lower depending on whether you’re male or female.
The Number Varies Dramatically by Country
Where you live shapes your cancer risk more than most people realize. Age-standardized cancer rates (which adjust for population age differences) vary enormously around the world. Australia has the highest rate at 462.5 per 100,000, followed by New Zealand at 427.3 and Denmark at 374.7. The U.S. sits at 367.0.
Compare that to countries like India (98.5 per 100,000), Ethiopia (104.5), Bangladesh (105.6), or Nigeria (113.6). These differences reflect a combination of factors: screening practices that detect more cancers in wealthier nations, lifestyle exposures like diet and tobacco, UV exposure, and differences in average lifespan. A country where fewer people live into their 70s will naturally report fewer cancers, even if the underlying biological risk is similar.
About 4 in 10 Cases Are Preventable
A major WHO-affiliated study published in Nature Medicine estimated that 37.1% of the 18.7 million new cancer cases diagnosed worldwide in 2022 were linked to 30 modifiable risk factors. That’s roughly 7.1 million cases tied to things like tobacco use, alcohol, excess body weight, physical inactivity, UV exposure, and certain infections.
That number cuts both ways. Most cancers are not caused by lifestyle choices, which means even people who do everything “right” can develop cancer. But 4 in 10 is still a substantial share, and it represents the portion of cancer risk you have some control over.
More Cases Are Coming, but Not Because Risk Is Rising
The total number of cancer cases in the U.S. is projected to increase by about 49% between 2015 and 2050, rising from roughly 1.53 million to 2.29 million annual diagnoses. That sounds alarming, but the underlying per-person risk is not climbing. Age-adjusted cancer risk is predicted to hold steady in women (a 1% change) and actually decline slightly in men (a 9% drop).
The increase in raw case numbers is driven almost entirely by demographics: the U.S. population is growing and aging. As baby boomers and subsequent generations move into their 60s, 70s, and 80s, more people will be alive in the age range where cancer is most common. The risk per person isn’t getting worse, but the sheer number of people at high-risk ages is expanding.
Putting Your Own Risk in Context
The “1 in 2” headline, while not precisely accurate for the U.S., captures something real: cancer is common enough that most families will encounter it. But a population-level statistic doesn’t translate directly to your individual risk. Your age right now, your sex, your family history, your exposure to tobacco or UV radiation, your weight, and even where you live all shift the number significantly in one direction or the other.
A 30-year-old’s risk of being diagnosed with cancer in the next decade is vastly lower than a 65-year-old’s. The lifetime figure stacks all those future decades together, and most of the weight sits at the far end. That’s not a reason to ignore the statistic, but it is a reason to understand it as a long-horizon number rather than an immediate threat.